Fjarde Ap Fonden Bio Techne Corp Transaction History

Fjarde Ap Fonden

$9.04 Billion
Q1 2024

A detailed history of Fjarde Ap Fonden transactions in Bio Techne Corp stock. As of the latest transaction made, Fjarde Ap Fonden holds 21,400 shares of TECH stock, worth $1.53 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

21,400

Previous 21,500 0.47%

Holding current value

$1.53 Million

Previous $1.66 Million 9.22%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$65.98 - $77.09 $6,598 - $7,709	-100 Reduced 0.47%	21,400 $1.51 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $95,094 - $140,796	1,800 Added 9.14%	21,500 $1.66 Million
Q3 2023 Oct 23, 2023	BUY	$67.52 - $89.42 $33,760 - $44,710	500 Added 2.6%	19,700 $1.34 Million
Q2 2023 Aug 02, 2023	SELL	$73.76 - $85.98 $125,392 - $146,166	-1,700 Reduced 8.13%	19,200 $1.57 Million
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $580,122 - $701,622	-8,100 Reduced 27.93%	20,900 $1.55 Million

Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $1.66 Million - $7.26 Million	20,600 Added 245.24%	29,000 $2.4 Million
Q2 2022 Aug 11, 2022	SELL	$322.67 - $449.65 $806,675 - $1.12 Million	-2,500 Reduced 22.94%	8,400 $2.91 Million
Q1 2022 May 13, 2022	BUY	$353.85 - $487.79 $460,005 - $634,127	1,300 Added 13.54%	10,900 $4.72 Million
Q4 2021 Feb 15, 2022	SELL	$456.15 - $525.06 $547,380 - $630,071	-1,200 Reduced 11.11%	9,600 $4.97 Million
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $711,792 - $862,208	-1,600 Reduced 12.9%	10,800 $5.23 Million
Q2 2021 Aug 12, 2021	BUY	$387.35 - $450.26 $4.8 Million - $5.58 Million	12,400 New	12,400 $5.58 Million

Others Institutions Holding TECH

# of Institutions

581

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.81B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account